Halscion develops hydrogel scaffolds to improve wound and scar healing following the suturing of a wound.
HALSCION, INC. develops devices to improve wound healing and the resulting scar outcomes. The company offers single-use hydrogel scaffolds that are applied during surgery to the dermal-subdermal interface of wound by injection. Its products include biocompatible materials that provide a structural framework upon, which wound healing cells, such as fibroblasts migrate into the wound and organize. The company was incorporated in 2005 and is based in Suwanee, Georgia.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 28, 2012 | Debt Financing | $4.30M | 1 | — | — | Detail |
Apr 20, 2011 | Series Unknown | $3.50M | 1 | — | — | Detail |
Oct 23, 2009 | Series Unknown | $6M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Versant Ventures | — | Debt Financing |